Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells

Leukemia

Volumn 21, Issue 4, 2007, Pages 732-738

  Bringmann, A ^a   Schmidt, S M ^a   Weck, M M ^a   Brauer, K M ^a   von Schwarzenberg, K ^a   Werth, D ^a   Grunebach F ^a   Brossart, P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; ZOLEDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG MECHANISM; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 33947383077     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404556     Document Type: Article

References (40)

1. Clezardin P. Anti-tumour activity of zoledronic acid. Cancer Treat Rev 2005; 31: 1-8.
2. Clezardin P, Ebetino FH, Fournier PG. Bisphosphonates and cancer-induced bone disease: Beyond their antiresorptive activity. Cancer Res 2005; 65: 4971-4974.
3. Mundy GR. Bisphosphonates as anticancer drugs. Expert Opin Investig Drugs 1999; 8: 2009-2015.
4. Rogers MJ. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 2003; 9: 2643-2658.
5. Pataki A, Muller K, Green JR, Ma YF, Li QN, Jee WS. Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 1997; 249: 458-468.
6. Dicuonzo G, Vincenzi B, Santini D, Avvisati G, Rocci L, Battistoni F, Gavasci M et al. Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interferon Cytokine Res 2003; 23: 649-654.
7. Bertho N, Adamski H, Toujas L, Debove M, Davoust J, Quillien V. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction. Blood 2005; 106: 1734-1741.
8. Stoitzner P, Zanella M, Ortner U, Lukas M, Tagwerker A, Janke K et al. Migration of langerhans cells and dermal dendritic cells in skin organ cultures: Augmentation by TNF-alpha and IL-1beta. J Leukoc Biol 1999; 66: 462-470.
9. Devilder MC, Maillet S, Bouyge-Moreau I, Donnadieu E, Bonneville M, Scotet E. Potentiation of antigen-stimulated V gamma 9V delta 2T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J Immunol 2006; 176: 1386-1393.
10. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96: 384-392.
11. Reis e Sousa. Activation of dendritic cells: Translating innate into adaptive immunity. Curr Opin Immunol 2004; 16: 21-25.
12. Re F, Strominger JL. Heterogeneity of TLR-induced responses in dendritic cells: From innate to adaptive immunity. Immunobiology 2004; 209: 191-198.
13. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
14. Appel S, Bringmann A, Grunebach F, Weck MM, Bauer J, Brossart P. Epithelial specific transcription factor ESE-3 is involved in the development of monocyte derived DC. Blood 2005; 107: 3265-3270.
15. Appel S, Mirakaj V, Bringmann A, Weck MM, Grunebach F, Brossart P. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 2005; 106: 3888-3894.
16. Nencioni A, Lauber K, Grunebach F, Brugger W, Denzlinger C, Wesselborg S et al. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. Exp Hematol 2002; 30: 1020-1028.
17. Nencioni A, Grunebach F, Zobywlaski A, Denzlinger C, Brugger W, Brossart P. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J Immunol 2002; 169: 1228-1235.
18. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
19. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-585.
20. Chuah C, Barnes DJ, Kwok M, Corbin A, Deininger MW, Druker BJ et al. Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells. Leukemia 2005; 19: 1896-1904.
21. Miyake K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol 2004; 12: 186-192.
22. Ardeshna KM, Pizzey AR, Devereux S, Khwaja A. The P13 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000; 96: 1039-1046.
23. Franchi L, Condo I, Tomassini B, Nicolo C, Testi R. A caspaselike activity is triggered by LPS and is required for survival of human dendritic cells. Blood 2003; 102: 2910-2915.
24. Xie J, Qian J, Wang S, Freeman III ME, Epstein J, Yi Q. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: Involvement of mitogen-activated protein kinase p38. J Immunol 2003; 171: 4792-4800.
25. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430: 257-263.
26. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
27. Nakahara T, Uchi H, Urabe K, Chen Q, Furue M, Moroi Y. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. Int Immunol 2004; 16: 1701-1709.
28. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5-11.
29. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
30. Horng T, Barton GM, Medzhitov R. TIRAP: An adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2: 835-841.
31. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995; 373: 531-536.
32. Navarro L, David M. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J Biol Chem 1999; 274: 35535-35538.
33. Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 1998; 188: 2175-2180.
34. Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 2003; 306: 860-866.
35. Tamura T, Thotakura P, Tanaka TS, Ko MS, Ozato K. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 2005; 106: 1938-1947.
36. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J Immunol 2003; 170: 1131-1135.
37. Schiavoni G, Mattei F, Borghi P, Sestili P, Venditti M, Morse III HC et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004; 103: 2221-2228.
38. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201: 1435-1446.
39. Loscher CE, Draper E, Leavy O, Kelleher D, Mills KH, Roche HM. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 2005; 175: 4990-4998.
40. Xia CQ, Peng R, Beato F, Clare-Salzler MJ. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol 2005; 62: 45-54.